Pinnacle Medicines is an emerging peptide drug discovery company based in Doylestown, Pennsylvania. Pinnacle has raised substantial Series A funding led by OrbiMed and Qiming Venture Partners, with the goal to discover first and best-in-class peptide therapeutics. The highly accomplished and experienced team at Pinnacle will utilize their deep know-how in peptide drug discovery, pioneering structure and AI-based drug design tools to realize the full potential of peptide modality as safe, effective and convenient therapeutics for unmet medical needs.